GM

Gerhard Moldenhauer

DK Deutsches Krebsforschungszentrum: 7 patents #9 of 345Top 3%
ME Medi&Gene: 3 patents #12 of 91Top 15%
TM Technische Universität München: 1 patents #110 of 403Top 30%
UN Unknown: 1 patents #29,356 of 83,584Top 40%
Overall (All Time): #455,922 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
10730943 Means and methods for treating HBV infection and associated conditions Ulrike Protzer, Felix Bohne, Frank Momburg 2020-08-04
10711054 Trispecific binding molecules for treating HBV infection and associated conditions Ulrike Protzer, Felix Bohne, Oliver Quitt, Frank Momburg 2020-07-14
10513559 Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy Heinz Faulstich 2019-12-24
10400037 Binding molecules, especially antibodies, binding to L1CAM (CD171) Peter Altevogt, Sandra Lüttgau, John Hazin 2019-09-03
10059767 Means and methods for treating HBV infection and associated conditions Ulrike Protzer, Felix Bohne, Frank Momburg 2018-08-28
9676855 B7-H6 therapeutically active monoclonal antibody against B7-H6 polypeptide Adelheid Cerwenka 2017-06-13
9260521 Treatment of tumors using specific anti-L1 antibody Daniela Kelm, Peter Altevogt, Frank Breitling, Achim R. Krueger, Silke Baerreiter +5 more 2016-02-16
9233173 Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy Heinz Faulstich, Werner Simon, Jan Anderl, Christoph Müller 2016-01-12
8771960 Method for producing protein libraries and for selecting proteins from said libraries Frank Breitling, Annemarie Poustka, Thorsten Kühlwein, Sandra Lüttgau 2014-07-08
8580258 Treatment of tumors using specific anti-L1 antibody Daniela Kelm, Peter Altevogt, Frank Brietling, Achim R. Krueger, Silke Wolterink +5 more 2013-11-12
8138313 Treatment of tumors using specific anti-L1 antibody Daniela Kelm, Peter Altevogt, Frank Brietling, Achim Krüger, Silke Bärreiter +3 more 2012-03-20